Correlation Between Sydbank AS and Orphazyme

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sydbank AS and Orphazyme at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sydbank AS and Orphazyme into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sydbank AS and Orphazyme AS, you can compare the effects of market volatilities on Sydbank AS and Orphazyme and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sydbank AS with a short position of Orphazyme. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sydbank AS and Orphazyme.

Diversification Opportunities for Sydbank AS and Orphazyme

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Sydbank and Orphazyme is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Sydbank AS and Orphazyme AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orphazyme AS and Sydbank AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sydbank AS are associated (or correlated) with Orphazyme. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orphazyme AS has no effect on the direction of Sydbank AS i.e., Sydbank AS and Orphazyme go up and down completely randomly.

Pair Corralation between Sydbank AS and Orphazyme

Assuming the 90 days trading horizon Sydbank AS is expected to under-perform the Orphazyme. But the stock apears to be less risky and, when comparing its historical volatility, Sydbank AS is 2.79 times less risky than Orphazyme. The stock trades about -0.01 of its potential returns per unit of risk. The Orphazyme AS is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  109,500  in Orphazyme AS on September 3, 2024 and sell it today you would lose (11,500) from holding Orphazyme AS or give up 10.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sydbank AS  vs.  Orphazyme AS

 Performance 
       Timeline  
Sydbank AS 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Sydbank AS are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Sydbank AS is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Orphazyme AS 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Orphazyme AS are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Orphazyme exhibited solid returns over the last few months and may actually be approaching a breakup point.

Sydbank AS and Orphazyme Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sydbank AS and Orphazyme

The main advantage of trading using opposite Sydbank AS and Orphazyme positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sydbank AS position performs unexpectedly, Orphazyme can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orphazyme will offset losses from the drop in Orphazyme's long position.
The idea behind Sydbank AS and Orphazyme AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing